Boston Pharmaceuticals - About the company
Boston Pharmaceuticals is an unfunded company based in Cambridge (United States), founded in 2016 by Robert Armstron and Chris Viehbacher. It operates as a Pharmaceutical company focused on innovative drug development and therapeutic solutions. Boston Pharmaceuticals has not raised any funding yet.
Company Details
Pharmaceutical company focused on innovative drug development and therapeutic solutions, dedicated to advancing healthcare through research and development. The company is committed to discovering and delivering novel therapies to address unmet medical needs. It operates within the pharmaceutical industry, focusing on creating impactful solutions for patients. The company emphasizes innovation and scientific rigor in its approach to drug development. It strives to improve patient outcomes and contribute to the advancement of medical science through its work. The company is involved in the development of pharmaceutical products, aiming to provide effective treatments and improve the quality of life for individuals facing various health challenges.
- Email ID
- *****@bostonpharmaceuticals.com
- Registered Address
- Cambridge, Massachusetts
Key Metrics
Legal entities associated with Boston Pharmaceuticals
Boston Pharmaceuticals is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Nanomix Corp CIN: 1473579 , United States, Active | $0 - $1M (As on Dec 31, 2022) | - | - | |
Boston Pharmaceuticals Inc CIN: 810837665 , United States, Active | Dec 31, 1999 | - | 34 (As on Dec 31, 2024) | - |
Sign up to download Boston Pharmaceuticals' company profile
Boston Pharmaceuticals's funding and investors
Boston Pharmaceuticals has not raised any funding rounds yet.
Boston Pharmaceuticals' founders and board of directors
Founder? Claim ProfileThe founders of Boston Pharmaceuticals are Robert Armstron and Chris Viehbacher. Chris Viehbacher is the CEO of Boston Pharmaceuticals.
Here are the details of Boston Pharmaceuticals' key team members:
- Robert Armstron: Former Co-Founder CEO of Boston Pharmaceuticals.
- Chris Viehbacher: Co-Founder & CEO of Boston Pharmaceuticals.
- Chris Viehbacher: CEO of Boston Pharmaceuticals.
View details of Boston Pharmaceuticals's Founder profiles and Board Members
Boston Pharmaceuticals' employee count trend
Boston Pharmaceuticals has 51 employees as of Sep 26. Here is Boston Pharmaceuticals's employee count trend over the years:
Uncover Boston Pharmaceuticals' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Boston Pharmaceuticals's Investments and acquisitions
Boston Pharmaceuticals has made no investments or acquisitions yet.
Reports related to Boston Pharmaceuticals
Here is the latest report on Boston Pharmaceuticals's sector:
News related to Boston Pharmaceuticals
Filter this list•
GSK focuses on hepatology: acquired efimosfermin alfa from Boston Pharma for $2 billionDaily Health Industry•Jul 09, 2025•GSK, Boston Pharmaceuticals
•
GSK Completes Acquisition of Efimosfermin for Steatotic Liver Disease (SLD)Financial Times•Jul 07, 2025•GSK, Boston Pharmaceuticals
•
GSK’s Acquisition of EfimosferminGlobal Legal Chronicle•May 19, 2025•Cleary Gottlieb, GSK, Sullivan & Cromwell, Boston Pharmaceuticals
•
GSK to Spend $2 Billion on Liver Disease Drug Acquisitionclinicaltrialsarena.com•May 14, 2025•GSK, Boston Pharmaceuticals
•
Hillstar Bio secures $67M to develop next-gen precision immunotherapies for autoimmune diseases.PR Newswire•Mar 25, 2025•Hillstar Bio, Droia Ventures, Frazier Life Sciences, Novo Holdings and 3 others
•
R&D Boston Pharma, building off MASH momentum, mulls an IPO ahead of Phase 3 trialEndPoints News•Mar 15, 2025•Boston Pharmaceuticals
•
•
Boston Pharmaceuticals hits Phase 2 goals as it tries to keep up with MASH competitorsEndPoints News•Nov 15, 2024•Boston Pharmaceuticals
•
Boston Pharmaceuticals Appoints Dr. Margaret Koziel as New Chief Medical OfficerBusiness Wire•Jun 06, 2024•Boston Pharmaceuticals
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Boston Pharmaceuticals
Explore our recently published companies
- Emax Solution - Malaysia based, 2006 founded, Unfunded company
- Owens Nutrition - United Kingdom based, Unfunded company
- Indosport99 - Unfunded company
- HD Dynamics - Dana Point based, 2001 founded, Unfunded company
- Handyman Shane - Unfunded company
- Kidsvacances - France based, 2016 founded, Unfunded company
